Np mrd loader

Record Information
Version2.0
Created at2020-12-09 02:00:43 UTC
Updated at2021-07-15 16:49:29 UTC
NP-MRD IDNP0004546
Secondary Accession NumbersNone
Natural Product Identification
Common NameCaspofungin
Provided ByNPAtlasNPAtlas Logo
DescriptionCaspofungin, also known as cancidas, belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Caspofungin is found in Glarea lozoyensis. Caspofungin was first documented in 2003 (PMID: 12615851). Based on a literature review a significant number of articles have been published on Caspofungin (PMID: 34390244) (PMID: 34370582) (PMID: 34368017) (PMID: 34367400) (PMID: 34367087) (PMID: 34367086).
Structure
Thumb
Synonyms
ValueSource
Caspofungin acetateMeSH
CancidasMeSH
Caspofungin MSDMeSH
N-[(6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-Amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-5,8,11,17,20,23,25-heptahydroxy-15-[(1R)-1-hydroxyethyl]-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0,]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidateGenerator
Chemical FormulaC52H88N10O15
Average Mass1093.3310 Da
Monoisotopic Mass1092.64306 Da
IUPAC Name(10S,12R)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-10,12-dimethyltetradecanamide
Traditional Name(10S,12R)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-10,12-dimethyltetradecanamide
CAS Registry NumberNot Available
SMILES
CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)C(NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN
InChI Identifier
InChI=1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41?,42+,43+,44+,45+,46+/m1/s1
InChI KeyJYIKNQVWKBUSNH-HDVLJZKUSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Glarea lozoyensisNPAtlas
Chemical Taxonomy
Description Belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentOligopeptides
Alternative Parents
Substituents
  • Alpha-oligopeptide
  • Cyclic alpha peptide
  • Macrolactam
  • N-acyl-alpha amino acid or derivatives
  • Alpha-amino acid or derivatives
  • 1-hydroxy-2-unsubstituted benzenoid
  • Phenol
  • Fatty acyl
  • Monocyclic benzene moiety
  • Benzenoid
  • Fatty amide
  • N-acyl-amine
  • Tertiary carboxylic acid amide
  • 1,3-aminoalcohol
  • Pyrrolidine
  • Amino acid or derivatives
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Secondary alcohol
  • Lactam
  • Azacycle
  • Organoheterocyclic compound
  • Secondary amine
  • Secondary aliphatic amine
  • Polyol
  • Organic oxygen compound
  • Organic oxide
  • Primary amine
  • Amine
  • Organic nitrogen compound
  • Aromatic alcohol
  • Carbonyl group
  • Hydrocarbon derivative
  • Primary aliphatic amine
  • Alcohol
  • Organopnictogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP0.17ALOGPS
logP-4.8ChemAxon
logS-3.5ALOGPS
pKa (Strongest Acidic)8.75ChemAxon
pKa (Strongest Basic)9.76ChemAxon
Physiological Charge2ChemAxon
Hydrogen Acceptor Count18ChemAxon
Hydrogen Donor Count16ChemAxon
Polar Surface Area412.03 ŲChemAxon
Rotatable Bond Count23ChemAxon
Refractivity278.78 m³·mol⁻¹ChemAxon
Polarizability117.59 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
NPAtlas IDNPA010755
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID78445759
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCaspofungin
METLIN IDNot Available
PubChem Compound139586083
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Letscher-Bru V, Herbrecht R: Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother. 2003 Mar;51(3):513-21. doi: 10.1093/jac/dkg117. [PubMed:12615851 ]
  2. Holyk AA, Lindner AH, Lindner SE, Shippert BW: Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Am J Health Syst Pharm. 2021 Aug 14. pii: 6352367. doi: 10.1093/ajhp/zxab329. [PubMed:34390244 ]
  3. Espinel-Ingroff A, Sasso M, Turnidge J, Arendrup M, Botterel F, Bourgeois N, Bouteille B, Canton E, Cassaing S, Dannaoui E, Dehais M, Delhaes L, Dupont D, Fekkar A, Fuller J, Garcia-Effron G, Garcia J, Gonzalez GM, Govender NP, Guegan H, Guinea J, Houze S, Lass-Florl C, Pelaez T, Forastiero A, Lackner M, Magobo R: Etest ECVs/ECOFFs for detection of resistance in prevalent and three non-prevalent Candida spp. to triazoles and amphotericin B and Aspergillus spp. to caspofungin: Further assessment of modal variability. Antimicrob Agents Chemother. 2021 Aug 9:AAC0109321. doi: 10.1128/AAC.01093-21. [PubMed:34370582 ]
  4. Rollin-Pinheiro R, Almeida YC, Rochetti VP, Xisto MIDDS, Borba-Santos LP, Rozental S, Barreto-Bergter E: Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells. Front Cell Infect Microbiol. 2021 Jul 23;11:698662. doi: 10.3389/fcimb.2021.698662. eCollection 2021. [PubMed:34368017 ]
  5. Damavandi SA, Adib S, Ashayeri N: Brain mucormycosis in a child with acute lymphoblastic leukemia. Radiol Case Rep. 2021 Jul 23;16(9):2808-2811. doi: 10.1016/j.radcr.2021.06.049. eCollection 2021 Sep. [PubMed:34367400 ]
  6. Yang X, Chen W, Liang T, Tan J, Liu W, Sun Y, Wang Q, Xu H, Li L, Zhou Y, Wang Q, Wan Z, Song Y, Li R, Liu W: A 20-Year Antifungal Susceptibility Surveillance (From 1999 to 2019) for Aspergillus spp. and Proposed Epidemiological Cutoff Values for Aspergillus fumigatus and Aspergillus flavus: A Study in a Tertiary Hospital in China. Front Microbiol. 2021 Jul 22;12:680884. doi: 10.3389/fmicb.2021.680884. eCollection 2021. [PubMed:34367087 ]
  7. Guo P, Wu Z, Liu P, Chen Y, Liao K, Peng Y, He Y: Identification and Antifungal Susceptibility Analysis of Stephanoascus ciferrii Complex Species Isolated From Patients With Chronic Suppurative Otitis Media. Front Microbiol. 2021 Jul 21;12:680060. doi: 10.3389/fmicb.2021.680060. eCollection 2021. [PubMed:34367086 ]
  8. Boonsilp S, Homkaew A, Phumisantiphong U, Nutalai D, Wongsuk T: Species Distribution, Antifungal Susceptibility, and Molecular Epidemiology of Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand. J Fungi (Basel). 2021 Jul 19;7(7). pii: jof7070577. doi: 10.3390/jof7070577. [PubMed:34356956 ]
  9. Garcia-Rubio R, Hernandez RY, Clear A, Healey KR, Shor E, Perlin DS: Critical Assessment of Cell Wall Integrity Factors Contributing to in vivo Echinocandin Tolerance and Resistance in Candida glabrata. Front Microbiol. 2021 Jun 30;12:702779. doi: 10.3389/fmicb.2021.702779. eCollection 2021. [PubMed:34305871 ]
  10. Lazaridou M, Nanaki S, Zamboulis A, Papoulia C, Chrissafis K, Klonos PA, Kyritsis A, Vergkizi-Nikolakaki S, Kostoglou M, Bikiaris DN: Super absorbent chitosan-based hydrogel sponges as carriers for caspofungin antifungal drug. Int J Pharm. 2021 Sep 5;606:120925. doi: 10.1016/j.ijpharm.2021.120925. Epub 2021 Jul 23. [PubMed:34303816 ]
  11. Yassin Z, Lotfali E, Khourgami MR, Omidi N, Fattahi A, Nasrollahi SA, Ghasemi R: Caspofungin resistance in clinical Aspergillus Flavus isolates. J Mycol Med. 2021 Jul 5;31(4):101166. doi: 10.1016/j.mycmed.2021.101166. [PubMed:34293598 ]
  12. Singh S, Rudramurthy SM, Padhye AA, Hemashetter BM, Iyer R, Hallur V, Sharma A, Agnihotri S, Gupta S, Ghosh A, Kaur H: Clinical Spectrum, Molecular Characterization, Antifungal Susceptibility Testing of Exophiala spp. From India and Description of a Novel Exophiala Species, E. arunalokei sp. nov. Front Cell Infect Microbiol. 2021 Jul 2;11:686120. doi: 10.3389/fcimb.2021.686120. eCollection 2021. [PubMed:34277470 ]
  13. da Rocha LF, Pippi B, Joaquim AR, de Andrade SF, Fuentefria AM: 8-hydroxyquinoline-5-(N-4-chlorophenyl) sulfonamide and fluconazole combination as a preventive strategy for Candida biofilm in haemodialysis devices. J Med Microbiol. 2021 Jul;70(7). doi: 10.1099/jmm.0.001377. [PubMed:34259620 ]